Cargando…
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
Shortly after the onset of the COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has acquired numerous variations in its intracellular proteins to adapt quickly, become more infectious, and ultimately develop drug resistance by mutating certain hotspot residues. To keep...
Autores principales: | Padhi, Aditya K., Tripathi, Timir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450486/ https://www.ncbi.nlm.nih.gov/pubmed/36113178 http://dx.doi.org/10.1016/j.bbrc.2022.09.010 |
Ejemplares similares
-
Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation
por: Padhi, Aditya K., et al.
Publicado: (2021) -
A Warhead
Substitution Study on the Coronavirus Main
Protease Inhibitor Nirmatrelvir
por: Vankadara, Subramanyam, et al.
Publicado: (2022) -
High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance
por: Padhi, Aditya K., et al.
Publicado: (2020) -
Multicomponent Synthesis
of the SARS-CoV-2
Main Protease Inhibitor Nirmatrelvir
por: Preschel, H. Daniel, et al.
Publicado: (2023) -
Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir
por: Hu, Yanmei, et al.
Publicado: (2022)